Company intelligence / Profile preview

Curebase

San Francisco, California, United Statescurebase.com ↗

Ownership: Private
Employees: ~27
Development stage: Commercial

Overview

Curebase has established itself as a leading provider of decentralized clinical trial solutions. Its software enables end-to-end execution of virtual and hybrid studies with robust participant engagement tools. The company has been recognized as a leader among digital health platforms supporting decentralized research. It partners with sponsors to operationalize DCTs across therapeutic areas but does not sponsor its own investigational drugs or devices. No direct clinical results are reported since it serves as an enabler/platform rather than a product developer.

Industry: Contract Research Organization

Partnerships

Meru Health

Beyond the preview

Go deeper on Curebase.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Curebase.

Explore the full profile